Insider trading · Q3 2026 · CIK 1380106

Rapid Micro Biosystems, Inc. (RPID) insider trading.

In Q3 2026, insiders at Rapid Micro Biosystems, Inc. reported 3 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
3
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
2
Last filed
2026-07-24

Insiders

InsiderRelationshipTransactionsBuysSales
Kollender Richard SDirector200
Spignesi Robert G. Jr.Director, Officer · PRESIDENT AND CEO100

Transactions

3 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-07-24Kollender Richard SM (A)1,827$0.75133,826Form 4
2026-07-24Kollender Richard SM (A)1,681$0.75131,999Form 4
2026-07-22Spignesi Robert G. Jr.M (A)1,402$0.751,191,973Form 4

Transaction codes in this quarter

Get RPID insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1380106&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · RPID company page · Rapid Micro Biosystems, Inc. on SEC.gov

Questions

Are insiders buying or selling Rapid Micro Biosystems, Inc. (RPID)?

In Q3 2026, insiders at Rapid Micro Biosystems, Inc. reported 3 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Rapid Micro Biosystems, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/rpid.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.